Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.（KPTI）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kpti · 股价预测 · 20 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 20 位华尔街分析师
Buy
20 位分析师
共识
评级分布
12 个月目标价
High
$28.00
Consensus
$17.25
+102.9% upside
Low
$12.00
Median: $14.5 · Last Close: $8.50
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$17.25
102.9% upside
High Target
$28
229.4%
Low Target
$12
41.2%
Current Price
$8.50
as of today
Based on analyst price targets, the KPTI stock price prediction for the next 12 months ranges from $12 to $28. The consensus KPTI price forecast of $17.25 implies 102.9% upside from the current price of $8.50.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $8.71 | ↑ 2.52% |
1-day model range: $8.64–$8.79. Peak: $8.79 (+2.52%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -62.5% |
| 2029 | $3 | -67.2% |
| 2030 | $3 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KPTI · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-27 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-30 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | Baird | Maintains | Outperform→Outperform |
| 2026-02-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-04 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-10-13 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2025-10-09 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-09 | Baird | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Karyopharm Therapeutics Inc. (KPTI) stock. Of the recent 129 rating actions, 9 were upgrades and 13 were downgrades. 20 analysts currently cover KPTI.
分析师推荐趋势
KPTI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$137M
↓ 40.4% YoY
Revenue Next Year
$155M
↑ 13.2% YoY
EPS This Year
$-4.08
EPS Next Year
$-3.12
↓ 23.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast KPTI EPS of $-4.08 for the current fiscal year, based on estimates from 3 analysts. The KPTI revenue forecast is $137M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KPTI 股价预测由两类独立数据源支撑：来自 20 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KPTI 的共识目标价为 $17.25（+102.9% 上行空间），分析师共识为 Buy。
KPTI 的短期预测（明日）为 $8.71（+2.52%）。 KPTI 对 2027 年的股价预测均值为 $4。 KPTI 对 2030 年的预测区间为 $2–$3。
Karyopharm Therapeutics Inc. 在 NASDAQ 上市，代码 KPTI。KPTI 在 2027 年的整体展望偏积极，在覆盖分析师中约 70% 对应 Buy 共识。
常见问题
KPTI 预测 · 8 个问题根据 20 位华尔街分析师，KPTI 的 12 个月平均目标价为 $17.25，最高 $28.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $8.50，隐含约 +102.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.